Status:
NOT_YET_RECRUITING
Emotion Processing and Regulation in People with Intellectual Disability
Lead Sponsor:
Karolinska Institutet
Conditions:
Intellectual Disabilities (F70-F79)
Autism Spectrum Disorder
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
BACKGROUND Intellectual disability (ID) is neurodevelopmental disorder with social impairments, in areas such as interpersonal communication skills and emotion regulation. This overlaps with disabili...
Detailed Description
BACKGROUND Individuals with intellectual disability (ID) experience significant difficulties in interpreting, controlling, and expressing emotions. These deficits in emotion processing contribute to ...
Eligibility Criteria
Inclusion
- Clinically diagnosed with mild ID based on DSM-5 criteria, corresponding to a general IQ between 52-70.
- Can read and communicate in Swedish.
Exclusion
- Presence of severe sensory impairments (e.g., blindness, deafness)
- Current psychosis or affective disorder; significant neurologic disorders (e.g., epilepsy) or degenerative disorder (e.g.., dementia, Parkinson's disease) - Diagnosis of ADHD
- Ongoing substance abuse
- Specific medication that enhance cognitive performance (central stimulants) or psychotropic medication that could affect task performance (anti-epileptic medication)
- Emotion regulation therapy or corresponding psychotherapy last 12 months.
Key Trial Info
Start Date :
January 15 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06894264
Start Date
January 15 2026
End Date
December 30 2028
Last Update
March 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.